Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K223727

    Validate with FDA (Live)

    Device Name
    Lavieen
    Manufacturer
    Date Cleared
    2023-08-25

    (255 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Lavieen is indicated for use in dermatological procedures requiring coagulation of soft tissue, treatment of actinic keratosis and treatment of benign pigmented lesions such as, but not limited to, lentigos (sun spots) and ephelides (freckles).

    Device Description

    Lavieen is a thulium laser, producing a pulsed beam of coherent near-infrared light (1927 mm) upon activation by a footswitch. The beam is then directed to the treatment zone by means of an optical fiber coupled to a handpiece. An integrated LED touch screen gives the user control over the necessary laser system parameters. Lavieen is equipped with a 658 nm aiming beam.

    AI/ML Overview

    The provided text is a 510(k) Summary for the Lavieen laser system. This document focuses on demonstrating substantial equivalence to existing predicate devices rather than proving the device meets specific acceptance criteria through a clinical study.

    Therefore, the requested information regarding acceptance criteria, study design, expert involvement, and ground truth establishment, which are typical for studies validating AI/ML-based medical devices or new clinical claims, are largely not present in this document. No clinical studies were deemed necessary or performed for this device.

    Here's an analysis based on the provided text, highlighting what is present and what is missing:


    1. A table of acceptance criteria and the reported device performance

    This document does not specify "acceptance criteria" in the sense of predefined thresholds for clinical performance outcomes. Instead, it demonstrates substantial equivalence to predicate devices by comparing technical characteristics and intended use.

    Comparison Table for Substantial Equivalence (summarized from the document):

    Feature/ParameterProposed Device (Lavieen)Predicate Device #1 (LASEMD)Predicate Device #2 (Joule System)Substantially Equivalent (Yes/No/Comment)
    Intended UseDermatological procedures requiring coagulation of soft tissue, treatment of actinic keratosis, benign pigmented lesions (lentigos, solar lentigos, ephelides).SameSameYes
    Laser TypeThulium laserThulium laserThulium laserYes
    Laser Wavelength1927 nm1927 nm1927 nmYes
    Aiming Beam658 nm658 nm658 nmYes
    Beam DeliveryFiber and HandpieceFiber and HandpieceArticulated Arm or Fiber opticYes
    Emission ControlFoot SwitchFoot SwitchFoot SwitchYes
    Laser Power10W5W12WYes (within range of predicates)
    Pulse Duration0.1 - 20 msMax 20 msMax 20 msYes
    Pulse Repetition Rate67 - 240 Hz43.5 - 307.7 Hz0 - 3,000 HzYes (within range of predicates)
    Spot Size300 µm100 µm, 200 µm100 – 620 µmYes (similar to predicate device #2)

    Reported Device Performance (from "Non-Clinical Test Summary"):

    • Max output power: 10 W (This is a design specification, not a performance metric from a clinical study).
    • Electrical Safety & EMC: Compliance with IEC 60601-1, IEC 60601-1-2, IEC 60601-2-22, IEC 60825-1.
    • Software Validation: Designed and developed according to a software development process, verified and validated.
    • Biocompatibility: Handpiece Tip (ABS) in contact with intact skin for <24 hours, determined to be biocompatible.

    2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    Not applicable. The document explicitly states: "No clinical studies were considered necessary and performed." Therefore, there is no "test set" in the context of clinical data. The device's substantial equivalence was established through bench testing, engineering comparisons, and adherence to recognized standards.


    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    Not applicable. As no clinical studies were performed, no ground truth from experts was established for a test set.


    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. No clinical studies were performed.


    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. This device is a laser system, not an AI-assisted diagnostic tool. No MRMC studies were performed.


    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    Not applicable. This is a hardware medical device (laser surgical instrument), not a standalone algorithm.


    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    Not applicable. No clinical studies were performed that required establishing ground truth for performance evaluation against clinical outcomes. The "ground truth" for this submission revolves around engineering specifications, safety standards, and functional equivalence to legally marketed predicate devices.


    8. The sample size for the training set

    Not applicable. This document describes a laser medical device, not an AI/ML model that would require a "training set."


    9. How the ground truth for the training set was established

    Not applicable. As above, no training set was used for an AI/ML model for this device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1